Nancy A. DiMartino

402 total citations
9 papers, 337 citations indexed

About

Nancy A. DiMartino is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Nancy A. DiMartino has authored 9 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Nancy A. DiMartino's work include DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (3 papers) and Testicular diseases and treatments (2 papers). Nancy A. DiMartino is often cited by papers focused on DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (3 papers) and Testicular diseases and treatments (2 papers). Nancy A. DiMartino collaborates with scholars based in United States, France and Italy. Nancy A. DiMartino's co-authors include Theodore G. Krontiris, David Parkinson, H. David Mitcheson, Colin B. Begg, George Schneider, Stephen Davis, Paul J. Hesketh, Priscilla B. Caguioa, Desmond N. Carney and Rita A. Blanchard and has published in prestigious journals such as Nature, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Nancy A. DiMartino

9 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy A. DiMartino United States	5	236	97	79	52	51	9	337
F Kaye United States	6	288 1.2×	174 1.8×	43 0.5×	28 0.5×	52 1.0×	7	399
Peter Lichter Germany	5	230 1.0×	153 1.6×	56 0.7×	81 1.6×	78 1.5×	6	378
N E Heldin Sweden	11	193 0.8×	87 0.9×	66 0.8×	15 0.3×	55 1.1×	14	343
Marcus Valentine United States	4	317 1.3×	294 3.0×	78 1.0×	53 1.0×	68 1.3×	4	483
Gunnar B. Hansen Sweden	9	189 0.8×	95 1.0×	94 1.2×	39 0.8×	123 2.4×	9	336
Roser Calvo United States	9	243 1.0×	109 1.1×	39 0.5×	89 1.7×	75 1.5×	17	404
N C Cheng Netherlands	8	299 1.3×	100 1.0×	99 1.3×	26 0.5×	122 2.4×	11	454
Erika L.D. Mitchell United Kingdom	11	206 0.9×	93 1.0×	139 1.8×	67 1.3×	107 2.1×	15	352
Anjila Koul Sweden	6	249 1.1×	156 1.6×	97 1.2×	102 2.0×	91 1.8×	7	421
Norihiko TAKADA Japan	7	211 0.9×	218 2.2×	30 0.4×	38 0.7×	67 1.3×	26	364

Countries citing papers authored by Nancy A. DiMartino

Since Specialization

Citations

This map shows the geographic impact of Nancy A. DiMartino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy A. DiMartino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy A. DiMartino more than expected).

Fields of papers citing papers by Nancy A. DiMartino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy A. DiMartino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy A. DiMartino. The network helps show where Nancy A. DiMartino may publish in the future.

Co-authorship network of co-authors of Nancy A. DiMartino

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy A. DiMartino. A scholar is included among the top collaborators of Nancy A. DiMartino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy A. DiMartino. Nancy A. DiMartino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Facchini, Gaetano, Francesco Caponigro, Nancy A. DiMartino, et al.. (1995). A PHASE-II TRIAL OF 5-FLUOROURACIL, FOLINIC ACID, VINORELBINE IN PRETREATED PATIENTS WITH METASTIC COLORECTAL-CANCER. Oncology Reports. 2(4). 513–6. 2 indexed citations

Hesketh, Paul J., et al.. (1993). Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C. Cancer. 71(3). 717–720. 4 indexed citations

DiMartino, Nancy A., et al.. (1990). Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus.. PubMed. 47(5). 854–9. 28 indexed citations

Krontiris, Theodore G., et al.. (1987). Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.. Environmental Health Perspectives. 76. 147–153. 18 indexed citations

Krontiris, Theodore G., et al.. (1987). Human Hypervariable Sequences in Risk Assessment: Rare Ha-ras Alleles in Cancer Patients. Environmental Health Perspectives. 76. 147–147. 3 indexed citations

Krontiris, Theodore G., et al.. (1986). Human restriction fragment length polymorphisms and cancer risk assessment. Journal of Cellular Biochemistry. 30(4). 319–329. 38 indexed citations

Krontiris, Theodore G., et al.. (1985). Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature. 313(6001). 369–374. 234 indexed citations

Davis, Stephen, Nancy A. DiMartino, & George Schneider. (1982). Malignant Interstitial Cell Carcinoma of the Testis: Report of Two Cases with Steroid Synthetic Profiles, Response to Therapy and Review of the Literature. The Journal of Urology. 127(3). 611–611. 3 indexed citations

Davis, Stephen, Nancy A. DiMartino, & George Schneider. (1980). 17β-Hydroxysteroid Dehydrogenase Deficiency in Malignant Interstitial Cell Carcinoma of the Testis. The Journal of Clinical Endocrinology & Metabolism. 51(6). 1293–1297. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact